Methadone: applied pharmacology and use as adjunctive treatment in chronic pain

被引:67
作者
Brown, R
Kraus, C
Fleming, M
Reddy, S
机构
[1] Univ Wisconsin, Dept Family Med, Madison, WI 53715 USA
[2] Madison Hlth Serv Methadone Treatment Facil, Dept Populat Hlth Sci, Madison, WI USA
[3] Univ Wisconsin, Dept Pharm, Madison, WI 53715 USA
[4] Univ Wisconsin, Sch Med, Madison, WI 53715 USA
关键词
D O I
10.1136/pgmj.2004.022988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article reviews the unique pharmacological properties of methadone and outlines its appropriate clinical application, with focus upon its use in the treatment of chronic pain. Although methadone is most widely known for its use in the treatment of opioid dependence, methadone also provides effective analgesia. Patients who experience inadequate pain relief or intolerable side effects with other opioids or who suffer from neuropathic pain may benefit from a transition to methadone as their analgesic agent. Adverse effects, particularly respiratory depression and death, make a fundamental knowledge of methadone's pharmacological properties essential to the provider considering methadone as analgesic therapy for a patient with chronic pain.
引用
收藏
页码:654 / 659
页数:6
相关论文
共 63 条
  • [1] Fluvoxamine-methadone interaction
    Alderman, CP
    Frith, PA
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1999, 33 (01) : 99 - 101
  • [2] Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone
    Altice, FL
    Friedland, GH
    Cooney, EL
    [J]. AIDS, 1999, 13 (08) : 957 - 962
  • [3] The rediscovery of methadone for cancer pain management
    Ayonrinde, OT
    Bridge, DT
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (10) : 536 - 540
  • [4] Ball J.C., 1991, EFFECTIVENESS METHAD
  • [5] Barnett PG, 2000, MT SINAI J MED, V67, P365
  • [6] Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir
    Bart, PA
    Rizzardi, PG
    Gallant, S
    Golay, KP
    Baumann, P
    Pantaleo, G
    Eap, CB
    [J]. THERAPEUTIC DRUG MONITORING, 2001, 23 (05) : 553 - 555
  • [7] Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers
    Begré, S
    von Bardeleben, U
    Ladewig, D
    Jaquet-Rochat, S
    Cosendai-Savary, L
    Golay, KP
    Kosel, M
    Baumann, P
    Eap, CB
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (02) : 211 - 215
  • [8] BELLUCK P, 2003, NY TIMES 0209
  • [9] Fluoxetine addition to methadone in addicts: Pharmacokinetic aspects
    Bertschy, G
    Eap, CB
    Powell, K
    Baumann, P
    [J]. THERAPEUTIC DRUG MONITORING, 1996, 18 (05) : 570 - 572
  • [10] Bruera E, 1996, CANCER, V78, P852, DOI 10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO